In a time of increasingly bespoke healthcare, Elizabeth Philp has become a significant voice of innovation, notably in the fast-evolving field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a drive to make bespoke medications more available, challenging the standard one-size-fits-all app